Design
Review
Authors
Loading...
Reinforces hypertriglyceridemia consideration in ASCVD risk assessment; leaves open need for targeted outcome trials.
Key points are not available for this paper at this time.
Peng et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: